GENEQUANTUM

Our vision is to enhance global affordability and expand worldwide access to innovative ADC therapies, fulfilling truly unmet medical needs... GeneQuantum, headquartered in China, is a global leader in the ADC field, distinguished for its advancement of enzymatic site-specific conjugation technologies. Our pioneering technologies, iLDC and iGDC, serve as the foundation of our comprehensive ADC drug development platform, spanning from the initial design to seamless commercial production.

Also known as: GeneQuantum Healthcare (Suzhou), GeneQuantum Healthcare (Suzhou) Co., Ltd.

Primary location: San Francisco United States